These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 12616459)

  • 21. Antihypertensive strategy based on angiotensin II receptor blockers: a new gateway to reduce risk in hypertension.
    Tocci G; Sciarretta S; Facciolo C; Volpe M
    Expert Rev Cardiovasc Ther; 2007 Jul; 5(4):767-76. PubMed ID: 17605654
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dual blockade of the renin-angiotensin system in the progression of renal disease: the need for more clinical trials.
    Fernandez-Juárez G; Barrio V; de Vinuesa SG; Goicoechea M; Praga M; Luño J
    J Am Soc Nephrol; 2006 Dec; 17(12 Suppl 3):S250-4. PubMed ID: 17130270
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Angiotensin II receptor blockers in the treatment of the cardiovascular disease continuum.
    Chrysant SG
    Clin Ther; 2008; 30 Pt 2():2181-90. PubMed ID: 19281913
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Worsening renal failure in older chronic kidney disease patients with renal artery stenosis concurrently on renin angiotensin aldosterone system blockade: a prospective 50-month Mayo-Health-System clinic analysis.
    Onuigbo MA; Onuigbo NT
    QJM; 2008 Jul; 101(7):519-27. PubMed ID: 18375475
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Proteases and antiproteases in the progression of chronic renal insufficiency lesions. The role of the tissue renin-angiotensin system and the renin receptor].
    Nguyen G; Burcklé C; Sraer JD
    J Soc Biol; 2002; 196(4):281-4. PubMed ID: 12645296
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The endothelin system and its antagonism in chronic kidney disease.
    Dhaun N; Goddard J; Webb DJ
    J Am Soc Nephrol; 2006 Apr; 17(4):943-55. PubMed ID: 16540557
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Renin-angiotensin system and atherothrombotic disease: from genes to treatment.
    Jacoby DS; Rader DJ
    Arch Intern Med; 2003 May; 163(10):1155-64. PubMed ID: 12767951
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Testosterone and blood pressure regulation.
    Kienitz T; Quinkler M
    Kidney Blood Press Res; 2008; 31(2):71-9. PubMed ID: 18319594
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Renin-angiotensin-aldosterone system and progression of renal disease.
    Rüster C; Wolf G
    J Am Soc Nephrol; 2006 Nov; 17(11):2985-91. PubMed ID: 17035613
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Renin-angiotensin genes in renal development and the occurrence and progression of renal diseases.
    Hohenfellner K; Fogo A; Kon V
    Semin Nephrol; 1999 Mar; 19(2):148-54. PubMed ID: 10192247
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oral carbonaceous absorbent modifies renal function of renal ablation model without affecting plasma renin-angiotensin system or protein intake.
    Horike K; Usami T; Kamiya Y; Kamiya T; Yoshida A; Itoh S; Yamato H; Ise M; Kimura G
    Clin Exp Nephrol; 2003 Jun; 7(2):120-4. PubMed ID: 14586730
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hypertension mega-trials with cardiovascular end points: effect of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers.
    Kjeldsen SE; Julius S
    Am Heart J; 2004 Nov; 148(5):747-54. PubMed ID: 15523303
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Oral inhibitors of renin and their potential use as therapeutic agents in treating hypertension].
    Abassi Z; Armaly Z; Nakhoul F; Hoffman A
    Harefuah; 2008 Jun; 147(6):536-42, 573. PubMed ID: 18693632
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic polymorphisms of the renin-angiotensin system in end-stage renal disease.
    Buraczynska M; Ksiazek P; Drop A; Zaluska W; Spasiewicz D; Ksiazek A
    Nephrol Dial Transplant; 2006 Apr; 21(4):979-83. PubMed ID: 16384824
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Renin-angiotensin-aldosterone system blockade and renal protection: angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers?
    Ruilope LM
    Acta Diabetol; 2005 Apr; 42 Suppl 1():S33-41. PubMed ID: 15868118
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Renin-angiotensin system in kidney physiology and pathology].
    Łapiński R
    Postepy Hig Med Dosw; 2000; 54(5):639-56. PubMed ID: 11146891
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of renin-angiotensin-aldosterone system triple blockade on non-diabetic renal disease: addition of an aldosterone blocker, spironolactone, to combination treatment with an angiotensin-converting enzyme inhibitor and angiotensin II receptor blocker.
    Furumatsu Y; Nagasawa Y; Tomida K; Mikami S; Kaneko T; Okada N; Tsubakihara Y; Imai E; Shoji T
    Hypertens Res; 2008 Jan; 31(1):59-67. PubMed ID: 18360019
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New therapeutic strategies with combined renin-angiotensin system inhibitors for pediatric nephropathy.
    Zaffanello M; Franchini M; Fanos V
    Pharmacotherapy; 2008 Jan; 28(1):125-30. PubMed ID: 18154482
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Progression of chronic kidney disease: can it be prevented or arrested?
    Jaber BL; Madias NE
    Am J Med; 2005 Dec; 118(12):1323-30. PubMed ID: 16378772
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Does the intrarenal reactive oxygen species/angiotensinogen/renin-Angiotensin system axis play an important role in the progression of chronic kidney disease?
    Konishi Y; Imanishi M
    Clin Exp Pharmacol Physiol; 2009 Aug; 36(8):748-9. PubMed ID: 19473185
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.